Fugetaxis: active movement of leukocytes away from a chemokinetic agent
暂无分享,去创建一个
[1] M. Degli-Esposti,et al. Cytomegalovirus evasion of natural killer cell responses , 1999, Immunological reviews.
[2] T. Griffith,et al. A vision of cell death: insights into immune privilege , 1997, Immunological reviews.
[3] M. Tessier-Lavigne,et al. The axonal chemoattractant netrin-1 is also a chemorepellent for trochlear motor axons , 1995, Cell.
[4] M. Daucher,et al. Accumulation of human immunodeficiency virus‐specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection , 1997, European journal of immunology.
[5] S. Guller,et al. The Role of Placental Fas Ligand in Maintaining Immune Privilege at Maternal - Fetal Interfaces , 1999, Seminars in reproductive endocrinology.
[6] R. Rabin,et al. HIV-1 Tat protein mimicry of chemokines. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Bromberg,et al. Gene transfer of virally encoded chemokine antagonists vMIP-II and MC148 prolongs cardiac allograft survival and inhibits donor-specific immunity , 2000, Gene Therapy.
[8] R. Schreiber,et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.
[9] L Dryer,et al. Evolution of odorant receptors , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[10] R. Schreiber,et al. Eradication of established tumors by CD8+ T cell adoptive immunotherapy. , 2000, Immunity.
[11] T. Springer,et al. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) , 1996, The Journal of experimental medicine.
[12] M. Juan,et al. Chemokines Determine Local Lymphoneogenesis and a Reduction of Circulating CXCR4+ T and CCR7 B and T Lymphocytes in Thyroid Autoimmune Diseases1 , 2003, The Journal of Immunology.
[13] G. Kotwal. Poxviral mimicry of complement and chemokine system components: what's the end game? , 2000, Immunology today.
[14] N. Aiyar,et al. Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1alpha: implications for development of selective CXCR4 antagonists. , 2001, Immunology letters.
[15] E. Kremmer,et al. Thymic T Cell Development and Progenitor Localization Depend on CCR7 , 2004, The Journal of experimental medicine.
[16] James E. K. Hildreth,et al. T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: implications for HIV pathogenesis. , 1999, Journal of immunology.
[17] M. Uguccioni,et al. Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes. , 2003, Blood.
[18] N. Tarasova,et al. Spontaneous and Ligand-induced Trafficking of CXC-Chemokine Receptor 4* , 1998, The Journal of Biological Chemistry.
[19] H. Patel,et al. Chemokines: key players in cancer , 2003, Current medical research and opinion.
[20] T. Kenakin. Principles: receptor theory in pharmacology. , 2004, Trends in pharmacological sciences.
[21] P. Simmonds,et al. HIV-1 tropism and co-receptor use , 1997, Nature.
[22] M. Baggiolini. Chemokines and leukocyte traffic , 1998, Nature.
[23] J. Cyster,et al. Chemorepulsion and thymocyte emigration. , 2002, The Journal of clinical investigation.
[24] P. Murphy. Molecular piracy of chemokine receptors by herpesviruses. , 1994, Infectious agents and disease.
[25] U. Gompels,et al. RANTES Binding and Down-Regulation by a Novel Human Herpesvirus-6 β Chemokine Receptor1 , 2000, The Journal of Immunology.
[26] J. Leonard,et al. Efficacious immunomodulatory activity of the chemokine stromal cell-derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell-dependent antitumor responses. , 2002, Blood.
[27] F. Vianello,et al. A CXCR4-Dependent Chemorepellent Signal Contributes to the Emigration of Mature Single-Positive CD4 Cells from the Fetal Thymus1 , 2005, The Journal of Immunology.
[28] S. Boyden,et al. Natural antibodies and the immune response. , 1966, Advances in immunology.
[29] Martin A. Nowak,et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.
[30] Bernhard Moser,et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 , 1996, Nature.
[31] B. Walker,et al. T lymphocyte responses in HIV-1 infection: implications for vaccine development. , 1999, Current opinion in immunology.
[32] B. Walker,et al. Migration ofAntigen-Specific T Cells Away from CXCR4-Binding Human ImmunodeficiencyVirus Type 1gp120 , 2004, Journal of Virology.
[33] T. Meyer,et al. Efficient generation of human T cells from a tissue-engineered thymic organoid , 2000, Nature Biotechnology.
[34] S. Rosenberg,et al. Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.
[35] J. Streilein,et al. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. , 1993, Current opinion in immunology.
[36] J. Inazawa,et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. , 1995, Genomics.
[37] U. V. von Andrian,et al. Chemokine regulation of naïve T cell traffic in health and disease. , 2003, Seminars in immunology.
[38] S. Dudas,et al. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[39] S. Frøland,et al. Stromal Cell–Derived Factor-1&agr; in Unstable Angina: Potential Antiinflammatory and Matrix-Stabilizing Effects , 2002, Circulation.
[40] A. Schuchat,et al. Increased risk of meningitis and bacteremia due to Listeria monocytogenes in patients with human immunodeficiency virus infection. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[41] S. Wank,et al. G protein-coupled receptors in gastrointestinal physiology. I. CCK receptors: an exemplary family. , 1998, The American journal of physiology.
[42] A. Zlotnik,et al. The biology of chemokines and their receptors. , 2000, Annual review of immunology.
[43] I. Hewlett,et al. HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. , 1996, Journal of immunology.
[44] Barbara Bottazzi,et al. Autocrine Production of IL-10 Mediates Defective IL-12 Production and NF-κB Activation in Tumor-Associated Macrophages1 , 2000, The Journal of Immunology.
[45] F. Balkwill. Cancer and the chemokine network , 2004, Nature Reviews Cancer.
[46] F. Marincola,et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma , 1998, Nature Medicine.
[47] R. Billingham,et al. IMMUNE PRIVILEGE IN THE TESTIS: II. EVALUATION OF POTENTIAL LOCAL FACTORS , 1985, Transplantation.
[48] R. Proia,et al. Expression of the Sphingosine 1-Phosphate Receptor, S1P1, on T-cells Controls Thymic Emigration* , 2004, Journal of Biological Chemistry.
[49] A. Luster,et al. Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.
[50] H. Schuitemaker,et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics , 1995, The Journal of experimental medicine.
[51] J. Sodroski,et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.
[52] T. Curiel,et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells , 2001, Nature Medicine.
[53] T. Kenakin. G-protein coupled receptors as allosteric machines. , 2004, Receptors & channels.
[54] C. Alpers,et al. Expression of the fractalkine receptor (CX3CR1) in human kidney diseases. , 2002, Kidney international.
[55] J. Bluestone,et al. Antigenic Cancer Cells Grow Progressively in Immune Hosts without Evidence for T Cell Exhaustion or Systemic Anergy , 1997, The Journal of experimental medicine.
[56] M. Burdick,et al. CXC chemokines in angiogenesis , 2000, Journal of leukocyte biology.
[57] S. Brandt,et al. Plasmacytoid Dendritic Cell Recruitment by Immobilized CXCR3 Ligands1 , 2004, The Journal of Immunology.
[58] O. Yoshie,et al. Role of chemokines in trafficking of lymphocytes and dendritic cells. , 2000, International journal of hematology.
[59] P. Shrikant,et al. Control of syngeneic tumor growth by activation of CD8+ T cells: efficacy is limited by migration away from the site and induction of nonresponsiveness. , 1999, Journal of immunology.
[60] Stephen C. Peiper,et al. Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.
[61] Murphy Pm. Molecular piracy of chemokine receptors by herpesviruses. , 1994 .
[62] D. Lo,et al. In Vivo Inhibition of CC and CX3C Chemokine–induced Leukocyte Infiltration and Attenuation of Glomerulonephritis in Wistar-Kyoto (WKY) Rats by vMIP-II , 1998, The Journal of experimental medicine.
[63] A. Fauci,et al. Induction of phosphorylation and intracellular association of CC chemokine receptor 5 and focal adhesion kinase in primary human CD4+ T cells by macrophage-tropic HIV envelope. , 1999, Journal of immunology.
[64] R. Billingham,et al. Immunologically Privileged Sites in Transplantation Immunology and Oncology , 2015, Perspectives in biology and medicine.
[65] C. Tacchetti,et al. Monocyte‐derived dendritic cells and monocytes migrate to HIV‐Tat RGD and basic peptides , 1998, AIDS.
[66] H. Schuitemaker,et al. Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection. , 1998, The Journal of infectious diseases.
[67] L. Steidler,et al. Cytokines, chemokines and growth factors in the pathogenesis and treatment of inflammatory bowel disease. , 2003, Advances in experimental medicine and biology.
[68] D. Scadden,et al. Active movement of T cells away from a chemokine , 2000, Nature Medicine.
[69] J. Streilein. Tissue barriers, immunosuppressive microenvironments, and privileged sites: the eye's point of view. , 1993, Regional immunology.
[70] C. Boshoff,et al. Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV , 1996, Science.
[71] Sophie Dupuis,et al. Directional guidance of neuronal migration in the olfactory system by the protein Slit , 1999, Nature.
[72] M. Kreuter,et al. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. , 2004, The Journal of clinical investigation.
[73] A. Gruhler,et al. A comparison of viral immune escape strategies targeting the MHC class I assembly pathway , 1999, Immunological reviews.
[74] R. Gerszten,et al. Chemokines, leukocytes, and atherosclerosis. , 2000, The Journal of laboratory and clinical medicine.
[75] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[76] Mu-ming Poo,et al. A Ligand-Gated Association between Cytoplasmic Domains of UNC5 and DCC Family Receptors Converts Netrin-Induced Growth Cone Attraction to Repulsion , 1999, Cell.
[77] M. Poo,et al. Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides. , 1998, Science.
[78] Streilein Jw. Tissue barriers, immunosuppressive microenvironments, and privileged sites: the eye's point of view , 1993 .
[79] J. Trapani,et al. A fresh look at tumor immunosurveillance and immunotherapy , 2001, Nature Immunology.
[80] B. Walker,et al. The great escape – AIDS viruses and immune control , 1999, Nature Medicine.
[81] C. Power,et al. Definition, function and pathophysiological significance of chemokine receptors. , 1998, Trends in pharmacological sciences.
[82] Alberto Mantovani,et al. Inflammation and cancer: back to Virchow? , 2001, The Lancet.
[83] W. Holzgreve,et al. Severely reduced presence of tissue macrophages in the basal plate of pre-eclamptic placentae. , 2001, Placenta.
[84] D. Scadden,et al. Thymocyte emigration is mediated by active movement away from stroma-derived factors. , 2002, The Journal of clinical investigation.
[85] J. Laurence,et al. ‘Reverse gear’ cellular movement mediated by chemokines , 2001, Immunology and cell biology.
[86] B. Sykes,et al. Solution structure and basis for functional activity of stromal cell‐derived factor‐1; dissociation of CXCR4 activation from binding and inhibition of HIV‐1 , 1997, The EMBO journal.
[87] T. Kepler,et al. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. , 1999, AIDS research and human retroviruses.
[88] F. Marincola,et al. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. , 2000, Advances in immunology.
[89] J. Fallon,et al. The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium. , 2001, Blood.
[90] R. Perlmutter,et al. A pertussis toxin‐sensitive process controls thymocyte emigration , 1991, European journal of immunology.
[91] Dirk Schadendorf,et al. Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells , 1998, Nature Medicine.
[92] A. Arvin,et al. Immune evasion mechanisms of varicella-zoster virus. , 2001, Archives of virology. Supplementum.
[93] W. Neaves,et al. Immune privilege in the testis. I. Basic parameters of allograft survival. , 1983, Transplantation.
[94] D. Missé,et al. A CD4-independent interaction of human immunodeficiency virus-1 gp120 with CXCR4 induces their cointernalization, cell signaling, and T-cell chemotaxis. , 1999, Blood.
[95] R. Bonavia,et al. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. , 2003, Cancer research.
[96] S. Shchelkunov,et al. Molecular mimicry of the inflammation modulatory proteins (IMPs) of poxviruses: evasion of the inflammatory response to preserve viral habitat , 1998, Journal of leukocyte biology.
[97] M. Lotz,et al. Factors influencing chemotaxis of the polymorphonuclear leucocyte. , 1956, British journal of experimental pathology.
[98] M. Daucher,et al. Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[99] M. Bessis,et al. Positive and negative chemotaxis as observed after the destruction of a cell by U. V. or laser microbeams. , 1965, Texas reports on biology and medicine.
[100] A. Fauci,et al. The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.
[101] A. Zlotnik,et al. Chemokines: a new classification system and their role in immunity. , 2000, Immunity.
[102] S. Fujita,et al. Enhancement of anti‐tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI‐1‐ligand chemokine and stromal cell–derived factor‐1αchemokine genes , 2001, International journal of cancer.
[103] H. Ioachim,et al. Immunopathogenesis of human immunodeficiency virus infection. , 1990, Cancer research.
[104] T. Honjo,et al. Signal sequence trap. Expression cloning method for secreted proteins and type 1 membrane proteins. , 1997, Methods in molecular biology.
[105] M. Raffeld,et al. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.
[106] S. Wank. I. CCK receptors: an exemplary family. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[107] E. De Clercq,et al. Evaluation of SDF‐1/CXCR4‐induced Ca2+ signaling by fluorometric imaging plate reader (FLIPR) and flow cytometry , 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[108] J. Hoxie,et al. Identification and characterization of the CXCR4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity. , 1998, Journal of immunology.
[109] V. Sasseville,et al. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages , 1999, Nature Medicine.
[110] E. Robey,et al. The Ins and Outs of CCR7 in the Thymus , 2004, The Journal of experimental medicine.
[111] R. Strieter. Chemokines: Not just leukocyte chemoattractants in the promotion of cancer , 2001, Nature Immunology.